Advertisement

Topics

Targos Molecular Pathology GmbH Company Profile

10:48 EST 20th November 2018 | BioPortfolio

"Targos focuses on the application, discovery and development of predictive biomarkers in oncology. Targeted therapies in oncology usually require biomarker guidance in development and clinical application for ethical, economic and regulatory reasons. Targos combines molecular pathology expertise with highly standardized analytics and applies strict project and quality management to provide the international pharma and diagnostic industry with customer-oriented premier biomarker services. In addition, Targos is active in the definition of proprietary biomarkers."

Location

Germany


News Articles [878 Associated News Articles listed on BioPortfolio]

Association for Molecular Pathology announces 2018aAward recipients

(Association for Molecular Pathology) AMP has announced the recipients of this year's Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award. The...

Association for Molecular Pathology announces 2018 Award recipients

(Association for Molecular Pathology) AMP has announced the recipients of this year's Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award and Meritorious Service Award. The...

Molecular P-Tau Status May Track Alzheimer Pathology, Symptoms

(MedPage Today) -- Specific type of tau phosphorylation site tied to amyloid pathology in familial AD

Deploying Digital Pathology in the Autopsy Service Before Surgical Pathology

I believe that most pathology teaching programs in the U.S. will be feeling a need to launch a digital pathology program soon because pathology house officer and fellow candidates are favoring those p...

Pathology Departments Should Consider Launching a Digital Pathology Outreach Program

For about five years, some academic pathology programs have launched surgical pathology consulting programs, often serving countries like China with a shortage of highly trained pathologists (see: Chi...

LenioBio GmbH and Fraunhofer IME to Advance Novel Protein Discoveries Through a License Agreement

DUSSELDORF and AACHEN, Germany, August 1, 2018 /PRNewswire/ -- Life sciences startup LenioBio GmbH and the Fraunhofer Institute for Molecular Biology and Applied Ecology IME Read more...

GSK3β in the prefrontal cortex: a molecular handle specific to addiction pathology?

Molecular classification in brain tumours

Dr Gilbert talks to ecancer at the Cancer Research UK Brain Tumour Conference 2018 in London about the use of molecular classification in brain tumours and whether classical pathology supersedes it. ...

PubMed Articles [1521 Associated PubMed Articles listed on BioPortfolio]

Molecular Diagnostics in Pathology.

Ethical considerations for modern molecular pathology.

Molecular pathology is becoming an increasingly important discipline in oncology, as molecular tumor characteristics will increasingly determine targeted clinical cancer care. In recent years, many te...

Genetic Analysis of Copy Number Variation in Large Chorangiomas.

Chorangioma (CA) is the most common nontrophoblastic, vascular tumor-like lesion of the placenta with a reported incidence of 0.5% to 1% in all examined placentas. The underlying molecular mechanisms ...

Biomarkers for diseases with TDP-43 pathology.

The discovery that aggregated transactive response DNA-binding protein 43 kDa (TDP-43) is the major component of pathological ubiquitinated inclusions in amyotrophic lateral sclerosis (ALS) and fron...

System for Informatics in the Molecular Pathology Laboratory (SIMPL): An Open-Source End-to-End Solution for Next-Generation Sequencing Clinical Data Management.

Next-generation sequencing (NGS) diagnostic assays are increasingly becoming the standard of care in oncology practice. As the scale of an NGS laboratory grows, management of these assays requires org...

Clinical Trials [2111 Associated Clinical Trials listed on BioPortfolio]

Molecular Pathology of Colorectal Cancer: Investigating the Role of Novel Molecular Profiles, microRNA's, and Their Targets in Colorectal Cancer Progression

Molecular pathology of Colorectal Cancer: Investigating the role of novel molecular profiles, microRNA's and their targets in Colorectal Cancer progression

iMarkHD: In Vivo Longitudinal Imaging of HD Pathology

iMarkHD is an innovative clinical imaging study and collaboration between the CHDI Foundation and Professor Marios Politis from King's College London (KCL) designed to assess longitudinal ...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

Mutation Analysis of 17α-Hydroxylase

To elucidate the molecular pathology of the 4 families with 17α-hydroxylase/17,20-lyase deficiency.

Mutation Analysis of 17βhydroxysteroid Dehydrogenase 3 Deficiency

To disclose the molecular pathology of our 3 families with 17βHSD3 deficiency.

Companies [1513 Associated Companies listed on BioPortfolio]

Targos Molecular Pathology GmbH

"Targos focuses on the application, discovery and development of predictive biomarkers in oncology. Targeted therapies in oncology usually require biomarker guidance in development and clinical applic...

Lakewood Pathology Associates

Lakewood Pathology Associates (LPA) is a national anatomical pathology company providing comprehensive and dynamic pathology services tailored to the outpatient needs of surgeons of diverse specialtie...

HistoRx, Inc

HistoRx is a bioscience company applying quantitative tools of molecular and cellular biology to develop new tools for pathology.HistoRx has introduced the first tissue-based quantitative molecular as...

The Association for Molecular Pathology (AMP)

The Association for Molecular Pathology (AMP) was founded in 1995 to provide structure and leadership to the emerging field of molecular diagnostics. Through the efforts of its Bo...

Association for Molecular Pathology (AMP)

The Association for Molecular Pathology (AMP) was founded in 1994 to provide structure and leadership to what was, at the time, the newly‐emerging field of molecular diagnost...

More Information about "Targos Molecular Pathology GmbH" on BioPortfolio

We have published hundreds of Targos Molecular Pathology GmbH news stories on BioPortfolio along with dozens of Targos Molecular Pathology GmbH Clinical Trials and PubMed Articles about Targos Molecular Pathology GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Targos Molecular Pathology GmbH Companies in our database. You can also find out about relevant Targos Molecular Pathology GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record